Well much of the criticism is justified IMO as they have dropped the ball and communicated poorly to the point of being misleading. Yes biotech and approvals take time but consideration must be given to how much of that extra time was caused by the company or the process. We will never know but clearly IMO the company hasn't been 100% 9on the ball for the whole process and it has cost shareholders time and money.
AGM crowds are those who can attend and don't represent the full spectrum of holders.
Brickwalls I am glad you can find no criticism in TIS in the past 3 years and all I can suggest is you package up those rose coloured glasses and market them as there is a whole audience of investors out there who needs them so they only see the good
There will always be differing opinion son time, approvals manner in which the company is being run as we all have differing investment strategy and have entered TIS at different times for different reasons.
TIS Price at posting:
22.5¢ Sentiment: None Disclosure: Held
